Structure of a dengue virus envelope protein late-stage fusion intermediate

Journal of Virology

Volumn 87, Issue 4, 2013, Pages 2287-2293

  Klein, Daryl E ^a,b   Choi, Jason L ^a   Harrison, Stephen C ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DENGUE VIRUS 1; HYDROPHOBICITY; MEMBRANE FUSION; MEMBRANE STRUCTURE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; VIRAL PHENOMENA AND FUNCTIONS; VIRUS FUSION; VIRUS MORPHOLOGY;

AMINO ACID SEQUENCE; CRYSTALLOGRAPHY, X-RAY; DENGUE VIRUS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; VIRAL ENVELOPE PROTEINS;

EID: 84873849253     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02957-12     Document Type: Article

References (27)

1. Lindenbach BD, Thiel H-J, Rice CM. 2007. Flaviviridae: replication. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 1. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Harrison SC. 2008. Viral membrane fusion. Nat. Struct. Mol. Biol. 15: 690-698.
3. Modis Y, Ogata S, Clements D, Harrison SC. 2003. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 100:6986-6991.
4. Modis Y, Ogata S, Clements D, Harrison SC. 2004. Structure of the dengue virus envelope protein after membrane fusion. Nature 427:313- 319.
5. Allison SL, Schalich J, Stiasny K, Mandl CW, Heinz FX. 2001. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J. Virol. 75:4268-4275.
6. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375:291-298.
7. Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S, Lescar J, Heinz FX, Rey FA. 2004. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation.EMBOJ. 23:728- 738.
8. Nayak V, Dessau M, Kucera K, Anthony K, Ledizet M, Modis Y. 2009. Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J. Virol. 83: 4338-4344.
9. Stiasny K, Allison SL, Marchler-Bauer A, Kunz C, Heinz FX. 1996. Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J. Virol. 70:8142- 8147.
10. Zhang W, Chipman PR, Corver J, Johnson PR, Zhang Y, Mukhopadhyay S, Baker TS, Strauss JH, Rossmann MG, Kuhn RJ. 2003. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat. Struct. Biol. 10:907-912.
11. Allison SL, Stiasny K, Stadler K, Mandl CW, Heinz FX. 1999. Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J. Virol. 73:5605-5612.
12. Liao M, Kielian M. 2005. Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion. J. Cell Biol. 171:111-120.
13. Pangerl K, Heinz FX, Stiasny K. 2011. Mutational analysis of the zippering reaction during flavivirus membrane fusion. J. Virol. 85:8495- 8501.
14. Olsen LR, Zhang GL, Reinherz EL, Brusic V. 2011. FLAVIdB: a data mining system for knowledge discovery in flaviviruses with direct applications in immunology and vaccinology. Immunome Res. 7:1-9.
15. Klein DE, Nappi VM, Reeves GT, Shvartsman SY, Lemmon MA. 2004. Argos inhibits epidermal growth factor receptor signalling by ligand sequestration. Nature 430:1040 -1044.
16. Klein DE, Stayrook SE, Shi F, Narayan K, Lemmon MA. 2008. Structural basis for EGFR ligand sequestration by Argos. Nature 453:1271- 1275.
17. Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
18. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J. Appl. Crystallogr. 40: 658-674.
19. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Pythonbased system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66:213-221.
20. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66:486 -501.
21. Krissinel E, Henrick K. 2007. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372:774-797.
22. Kanai R, Kar K, Anthony K, Gould LH, Ledizet M, Fikrig E, Marasco WA, Koski RA, Modis Y. 2006. Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J. Virol. 80:11000- 11008.
23. Nybakken GE, Nelson CA, Chen BR, Diamond MS, Fremont DH. 2006. Crystal structure of the West Nile virus envelope glycoprotein. J. Virol. 80:11467-11474.
24. Dubey KD, Chaubey AK, Ojha RP. 2012. Stability of trimeric DENV envelope protein at low and neutral pH: an insight from MD study. Biochim. Biophys. Acta 1834:53-64.
25. Luca VC, Nelson CA, Fremont DH. 2012. Structure of the St. Louis encephalitis virus postfusion envelope trimer. J. Virol. doi:10.1128/JVI.01950-12.
26. Schmidt AG, Yang PL, Harrison SC. 2010. Peptide inhibitors of denguevirus entry target a late-stage fusion intermediate. PLoS Pathog. 6:e1000851. doi:10.1371/journal.ppat.1000851.
27. Schmidt AG, Yang PL, Harrison SC. 2010. Peptide inhibitors of flavivirus entry derived from the E protein stem. J. Virol. 84:12549-12554.